Doctor discusses Ivermectin success in India, questions Canada’s COVID approach
03/12/2021 No Comments
No matter where you stand on how to best handle pandemic policy, Dr. Da Costa’s experience and view is worth a listen.
No matter where you stand on how to best handle pandemic policy, Dr. Da Costa’s experience and view is worth a listen.
In Dr. Ozaki’s recent speech, he declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. The head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.
Just as Galileo proved with his telescope that the earth was NOT the center of the Universe in 1616; today, the data from India shows that Ivermectin is effective, much more so than the vaccines. It not only prevents death, but it also prevents COVID infections, and it also is effective against the Delta Variant.
Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.
During the first wave, the primary antiviral used was HCQ, and during the second wave (after Facebook censored his account where he was communicating with others in a large nation) they shifted to ivermectin due to HCQ controversies. Similarly to the way Dr. Brian Tyson attacked COVID-19 with an early multi-drug regimen, numerous other medicines, including aspirin, were used. Of Dr. Shah’s 8,000 or so patients, only 5 succumbed to COVID-19. This is notably similar to the results of Dr. Didier Raoult.
Ivermectin is on the WHO’s list of essential medicines and has a high safety profile with more than 3.7 billion doses having been distributed in more than 30 years.
This is pulled straight from the same playbook as the propaganda against HCQ. Even if you’re not sure that one or both of these medicines is effective despite uniformly positive results when applied as early treatment, you should at least recognize the pattern, scratch your head, and question whether there is…maybe…just possibly some perverse incentive like power or profit from vaccines driving this absurdity.
Source: India Today Author: Prabhash K Dutta Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year,
Just as fast as new cases materialized so has the decline thanks in part to a coordinated public health strategy that includes proactive testing, home visits, and medication kits that include ivermectin.
With ivermectin now on the national Indian COVID-19 list of recommended treatments for COVID-19, a few states have gone to the next level and included the low-cost, generic drug approved throughout the world as a parasite fighter as a prophylactic targeting SARS-CoV-2, the virus behind COVID-19.
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
TrialSite hosted the first international Ivermectin for Covid Summit webinar on Sunday, May 23rd 2021. The event was widely attended with medical experts presenting from around the world to a global audience of interested parties in the thousands.
Both Goa and Karnataka are rolling out mass Ivermectin programs in a bid to reduce infection, transmission, and death rates associated with COVID-19. TrialSite reported two days ago that the State of Goa embraced the national Ivermectin guidelines, and as reported in The Mint and other outlets, Vishwajit Rane, Goa’s Health Minister, declared that all people 18 years and up would have access to the generic drug regardless of COVID-19 status in an aggressive bid to lower infection rates and total deaths associated with SARS-CoV-2.
Today, most leading doctors in India are themselves not promoting the Ministry of Health guidelines that includes the use of hydroxychloroquine, ivermectin and inhaled budesonide.
So, what’s different between Maharashtra and Delhi with respect to the rest of India and South Asia? Instead of relying on HCQ and IVM, many doctors and health officials in Maharashtra and Delhi pushed the expensive and profitable remdesivir drug. Due to its cost and recommended time of usage, remdesivir is not used either as a prophylaxis or for early outpatient treatment. And unlike the cheap and easy-to-produce HCQ and IVM, remdesivir is difficult to replace when it runs out.
It would be a historically amazing feat of maneuvering bureaucracy, worthy of its own epic book, movie, or perhaps a campfire song, to have wrangled that much data out of those hospitals with highly variable regulations and procedures, nearly all of which are in the U.S. healthcare system.
“I am deeply troubled that the WHO made this hasty decision on guidance before reviewing all available data,” said Pierre Kory, MD, MPH, president and chief medical officer of the FLCCC.
“Their recommendation ignores the evidence, creates more controversy, and will only lead to continuing suffering and death from COVID-19. There are now over 24 randomized trials results
that have been reported to the Unitaid/WHO team yet todays guidance was inexcusably based on a faulty analysis of just 16 of the available trials. Further, these erroneous findings directly conflict
with numerous other peer-reviewed expert analyses that have found the data overwhelmingly demonstrates that ivermectin saves lives from COVID-19. There is no reason not to recommend it
for everyone as a safe drug for prevention and treatment.”
The group that didn’t take the ivermectin, over 3 months it was fifty-eight percent. Fifty-eight percent of those doctors, nurses and orderlies contracted coronavirus.
In the 788 group, the same doctors, nurses and orderlies across the 4 hospitals, the number of infections that they had, was zero. ZERO, that were treated with ivermectin.
India has conquered the disease with hydroxychloroquine and ivermectin, uses a traditional vaccine, exports experimental vaccines for these idiotic Westerners … There are 1,230 deaths per million inhabitants over 65 (six times less than in France). If we had listened to Raoult and followed the Indian model, today we would have 500 cases of covid per day and 75,000 fewer deaths …
Early treatment intervention with hydoxychloroquine & Ivermectin appears to have played a major role in control in India, precipitating local herd immunity.
We conclude that two-dose ivermectin prophylaxis at a dose of 300 μg/kg body weight with a gap of 72 hours was associated with a 73% reduction of SARS-CoV-2 infection among HCWs in the following one month. Chemoprophylaxis has relevance in the containment of pandemic. This is an intervention worth replicating at other centers until a vaccine is widely available.
With such a rate of contamination, we are faced with a scenario of collective quasi-immunity managed with a broad prescription of early and prophylactic treatment based on hydroxychloroquine. With a contamination rate of 56%, mortality is 549 people per million inhabitants. Last December, the Institut Pasteur estimated the rate of the French population to be contaminated at 11.3% [1]. Mortality in France is 1200 [2] people per million inhabitants. The population of Delhi is five times more contaminated with mortality more than two times lower compared to France. The case fatality rate with early treatment in Delhi, which is 0.1%, is close to the rate estimated by Professor Raoult in the case of early treatment.
Source: TrialSiteNews Author: Mary Beth Pfeiffer She is a gynecologist. He is a surgeon. They are married and both 77 years old. In mid-November, they
Source: Journal of Marine Medical Society Date of Submission 23-Aug-2020 Date of Decision 18-Sep-2020 Date of Acceptance 29-Sep-2020 Date of Web Publication 06-Nov-2020 Correspondence Address:Vivek
Source: Steven Phillips, MD Indian Medical Association endorses prophylactic use of HCQ for the police department to prevent COVID19. The Bengal State Branch recommended to
Source: PubMed Kalyan Kumar Gangopadhyay 1, Binayak Sinha 2, Samit Ghosal 3 Background and aims: As the Coronavirus disease 2019 (COVID-19) pandemic unravels rapidly, there is a glut of confusing and
Nigeria has received seven tonnes of hydroxychloroquine from India.
The American media and bureaucracies should move beyond their obsession with politics and honestly consider HCQ’s efficacy.
Hydroxychloroquine, based on the science in articles like the one that originally appeared in 2005 in the Journal of Virology, works in a therapeutic way by raising the alkalinity of your cells which slows the replication of the virus and also can kill the virus.
The Vadodara administration has begun analysing the effects of the drug Hydroxychloroquine (HCQ) in containing the cases in the city.
See the original source: Sunday Guardian Live By Jacob Puliyel Gresham’s law holds that bad money drives out good money. If there are two coins
Source: The News Minute Medical shops in Hyderabad are seeing an unusual demand for multivitamin tablets as COVID-19 cases rise in the city. When this
He said the SMS hospital was the first hospital to use Hydroxychloroquine and anti-HIV Drugs Lopinavir and Ritonavir in the first few patients of COVID-19 which delivered good outcomes.
The US Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat Covid-19, but quickly came under fire from President Donald Trump, who said only US agencies have failed to grasp its benefit in fighting the coronavirus.
India’s ICMR, its official medical research agency, had written to the WHO, telling WHO that the hydroxychloroquine doses being used in the Solidarity trial were 4 times higher than the doses being used in India.
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research on chemoprophylaxis is still lacking even though it has potential
Source: India Times New Delhi: Union Minister of State for Chemicals and Fertilizers, Mansukh Mandaviya said that the production of Hydroxychloroquine is more than the requirement in India, hence
The fatality rate among the police personnel in Mumbai due to COVID-19 is just one per cent, thanks to the prophylactic use of HCQ.
Source: Times of India Nagpur: Preventive measures taken by city police’s medical teams seemed to have worked better for them in comparison to their counterparts
Source: Times of India NEW DELHI: With hydroxychloroquine regaining its credibility after WHO restarted its trials and the authors of a Lancet study slamming it falling into controversy, India’s Covid-19 diplomacy,